Merck (MRK)
Develops oncology medicines, vaccines, cardiopulmonary therapies, and animal-health products worldwide.
$148.02
vs last close−2.89 (−1.92%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 82.41% | 2.03B shares | |
|---|---|---|---|
| 3,945 holders · as of Jun 30, 2026 | |||
| Insiders | 0.04% | 1.03M shares | |
| 17 holders · as of Sep 1, 2026 | |||
| Other | 17.55% | 432.91M shares | |
| remainder | |||
2.47B company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
3,945 holders · 2.03B shares · 219 new positions · 1,847 increased · 1,513 reduced · 180 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 227.00M | 9.20% | +1.17M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 161.32M | 6.54% | +335.6K | Aug 13, 2026 |
| State Street Corp | 120.41M | 4.88% | +1.09M | Aug 7, 2026 |
| Wellington Management Group LLP | 86.25M | 3.50% | +1.93M | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 67.74M | 2.75% | +434.7K | Aug 13, 2026 |
| Geode Capital Management, LLC | 60.74M | 2.46% | +1.19M | Aug 12, 2026 |
| Charles Schwab Investment Management Inc | 54.37M | 2.20% | +4.60M | Aug 14, 2026 |
| Sixth Street Partners Management Company, L.P. | 54.37M | 2.20% | +54.37Mnew | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.53% | 186.32M | 13G | Apr 30, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 13, 2026 | Chirfi Guindoofficer: EVP, Access, Policy & Comms | Sale | 10,000 | $135.00 | 36,613 |
| Aug 12, 2026 | Jennifer Zacharyofficer: EVP, General Counsel | Sale | 80,315 | $133.46 | 45,509 |
| Aug 12, 2026 | Richard R. DeLucaofficer: EVP&Pres, Merck Animal Heallth | Sale · 2 lots | 11,699 | $131.63 | 110,167 |
| Aug 11, 2026 | Richard R. DeLucaofficer: EVP&Pres, Merck Animal Heallth | Sale · 2 lots | 12,837 | $131.76 | 121,866 |
| Aug 10, 2026 | Richard R. DeLucaofficer: EVP&Pres, Merck Animal Heallth | Sale | 20,784 | $130.43 | 134,703 |
| Aug 6, 2026 | Richard R. DeLucaofficer: EVP&Pres, Merck Animal Heallth | Sale · 3 lots | 6,050 | $130.38 | 155,487 |
| Aug 6, 2026 | Chirfi Guindoofficer: EVP, Access, Policy & Comms | Sale | 15,000 | $131.00 | 46,613 |
| Aug 5, 2026 | David Michael Williamsofficer: EVP,Chief Info&Digital Officer | Sale | 34,705 | $128.77 | 31,716 |
| Aug 5, 2026 | David R. Maraldoofficer: EVP & Pres. MMD | Sale | 2,686 | $128.72 | 18,212 |
| Feb 12, 2026 | Chirfi Guindoofficer: Chief Marketing Officer | Sale | 10,000 | $121.46 | 60,615 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Maria Elvira Salazar · FL27 | Purchase | $15,001 – $50,000 | Aug 19, 2026 | Sep 10, 2026 | |
| Rep. Maria Elvira Salazar · FL27 | Purchase | $15,001 – $50,000 | Aug 19, 2026 | Sep 10, 2026 | |
| Rep. Maria Elvira Salazar · FL27 | Purchase | $15,001 – $50,000 | Aug 19, 2026 | Sep 10, 2026 | |
| Rep. Ro Khanna · CA17 | Purchase | $15,001 – $50,000 | Aug 7, 2026 | Sep 7, 2026 | |
| Rep. Keith Self | Sale | $1,001 – $15,000 | Self | Jan 10, 2025 | Jul 1, 2026 |